Beyond that, scFv-CM6-DM1-liposome, an antibody-drug-conjugated immunoliposome, was generated to target CD248-overexpressing human neuroblastoma cells and enhance drug efficacy (Marty et al., 2006). This evidence concerns the gene CD248 and neuroblastoma.